Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

- PMLiVE

Pfizer’s Lorviqua recommended by NICE for lung cancer

Lung cancer is the leading cause of cancer-related deaths worldwide

- PMLiVE

Prime welcomes James Karcher to senior leadership team

Karcher has been appointed as global EVP, Medical Communications, AI and Digital Healthcare

- PMLiVE

Driving launch excellence with agile transformation

Examining the key risks and opportunities that biopharma asset teams should prioritise during R&D and launch

Amiculum - science that speaks volumes

New brand, same great team!

We’re excited to launch our refreshed Amiculum visual identity today. Our new brand encapsulates the vibrancy and creativity that we see every day from our team. It’s fresh, forward-looking and...

Amiculum

- PMLiVE

New study highlights global overuse of antibiotics for diverticulitis

Researchers warn that excessive antibiotic use in diverticulitis increases risk of antimicrobial resistance and unnecessary hospital admissions

- PMLiVE

Havas Life London appoints Fran Griffin as Head of Strategy

Griffin moves from BBH London to Havas Health

- PMLiVE

The Rashomon Effect

Why your cross-functional team gets cross

- PMLiVE

Stories of sickness: applying illness narratives to health advertising

By Dr Stephanie Goley Introduction As advertisers, we know that health and pharmaceutical campaigns hold enormous influence over how the public perceives illness, wellness, and treatment. But too often, our...

11 London

Young girl receives vaccine jab in her arm

Regaining trust in childhood vaccines: can better comms turn the tables on hesitancy and misinformation?

In the wake of Trump questioning MMR vaccines, we review the best practices in vaccine communications and consider how to reverse damage done to public trust in childhood vaccinations.

Say Communications

- PMLiVE

Medscape Education: Pioneering Pathways at ESMO 2025

Medscape Oncology will be pioneering pathways at the 2025 ESMO congress taking place in Berlin, Germany this October.

Medscape Education

- PMLiVE

PMLiVE’s T40 – now open for submissions!

Healthcare agencies can submit their entries free of charge with a deadline of 30 October

- PMLiVE

Roche’s small cell lung cancer therapy approved by FDA

This is the first and only approved combination therapy for extensive-stage small cell lung cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links